prof. Yolande Lievens
Show
Sort by
-
Interobserver delineation uncertainty in involved node therapy for early-stage Hodgkin lymphoma
-
Cost evaluations of radiotherapy: what do we know? : an ESTRO-HERO analysis
-
Unresectable stage III non-small-cell lung cancer : have we made any progress?
-
Implementation and clinical evaluation of automated planning for IMRT treatment of breast cancer
-
Prone breast irradiation: from indirect to direct tumor bed localization
-
The cost of radiotherapy: what do we know? : a systematic search of the literature between 1981 and 2015
-
Assessing the gap between evidence based indications for radiotherapy and actual practice in European countries
-
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?
-
Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology
-
The need for radiotherapy in Europe in 2020: not only data but also a cancer plan